Hidenori Komiyama

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika et al. · Cardiovascular Diabetology · 2020 · 232 citations · Full text

Medicine, Cardiology, Pharmacology +17

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon et al. · European Heart Journal · 2019 · 127 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak et al. · JACC: Cardiovascular Interventions · 2019 · 113 citations

Medicine, Cardiology, Clinical Sciences +17

Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Ply Chichareon, Rodrigo Modolo, Laura S.M. Kerkmeijer et al. · JAMA Cardiology · 2019 · 81 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Impact of Brain Natriuretic Peptide, Calcium Channel Blockers, and Body Mass Index on Recovery Time from Left Ventricular Systolic Dysfunction in Patients With Takotsubo Cardiomyopathy

Reiko Shiomura, Shunichi Nakamura, Hitoshi Takano et al. · The American Journal of Cardiology · 2015 · 25 citations

Medicine, Cardiology, Physiology +15